As Nashville cautiously begins to emerge from its two-month-long COVID-19 Safer at Home response, so too are the labs and facilities at Vanderbilt University Medical Center.

Manuel Ascano team validates an inhibitor of the cGAS-STING signaling pathway, which is important for cellular innate immunity against bacteria, viruses, and our own damaged DNA.

Pregnant women involved in the criminal justice system are disproportionately not receiving medications for opioid use disorder, as compared to their peers, according to a Vanderbilt-led study published today in PLOS Medicine.

Vanderbilt researchers used pharmacological manipulations to increase salt and water transport by kidney cells grown in culture, a step necessary for realizing an implantable artificial kidney device.

Consumer behavior expert, Kelly Goldsmith, PHD, delves into how conflicting motivations – a desire for normalcy and being safe – will play out as the economy begins to re-open in Nashville and Tennessee.

During a first-ever virtual leadership assembly necessitated through social distancing, Vanderbilt University Medical Center leaders answered questions about the Medical Center’s response to COVID-19 so far and what the future could hold.

Vanderbilt Vaccine Center team isolates monoclonal antibodies against Ross River virus, which causes rash, fever and debilitating muscle and joint pain lasting three to six months.